At the time of diagnosis of COVID-19 patients, 45/117 (38.57%) had high levels of ALT, 104/117 (97.44%) had high levels of CRP and 48/117 (41.3%) had high levels of AST (Table 2). This evidence concerns the gene GPT and COVID-19.